Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Assets Average (2020 - 2023)

Historic Assets Average for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to $487.1 million.

  • ADC Therapeutics' Assets Average fell 741.48% to $487.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $487.1 million, marking a year-over-year decrease of 741.48%. This contributed to the annual value of $245.7 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Assets Average is $487.1 million, which was down 741.48% from $487.5 million recorded in Q2 2023.
  • ADC Therapeutics' Assets Average's 5-year high stood at $564.7 million during Q4 2021, with a 5-year trough of $447684.0 in Q3 2020.
  • Over the past 4 years, ADC Therapeutics' median Assets Average value was $499.4 million (recorded in 2022), while the average stood at $449.1 million.
  • Per our database at Business Quant, ADC Therapeutics' Assets Average soared by 12301865.07% in 2021 and then crashed by 1155.49% in 2023.
  • Over the past 4 years, ADC Therapeutics' Assets Average (Quarter) stood at $447684.0 in 2020, then surged by 126039.16% to $564.7 million in 2021, then decreased by 9.46% to $511.3 million in 2022, then dropped by 4.73% to $487.1 million in 2023.
  • Its last three reported values are $487.1 million in Q3 2023, $487.5 million for Q2 2023, and $479.3 million during Q1 2023.